NFKB1 and pancreatic neoplasm: Collectively, these results support the idea that the secretion of IL8 by CAFR activated the NF-κB pathway in the pancreatic cancer cells, resulting in the upregulation of UPK1-AS1 and thereby facilitating oxaliplatin resistance in pancreatic cancer.